BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 386,470 shares, a drop of 61.2% from the September 30th total of 995,329 shares. Currently, 19.8% of the shares of the company are short sold. Based on an average daily volume of 7,692,228 shares, the short-interest ratio is presently 0.1 days.
BIO-key International Stock Up 15.0%
BIO-key International stock opened at $3.14 on Thursday. The firm has a fifty day moving average of $2.59 and a 200-day moving average of $4.60. The firm has a market capitalization of $6.41 million, a P/E ratio of -0.76 and a beta of 0.50. BIO-key International has a 52-week low of $1.55 and a 52-week high of $13.80.
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The technology company reported ($0.56) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.82) by $0.26. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. The firm had revenue of $1.92 million during the quarter, compared to analyst estimates of $1.80 million. On average, research analysts expect that BIO-key International will post -1.62 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on BKYI shares. Zacks Research upgraded shares of BIO-key International to a “hold” rating in a research report on Thursday, August 6th. Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a report on Thursday, October 15th. Finally, Wall Street Zen raised BIO-key International to a “hold” rating in a report on Saturday, October 24th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Reduce”.
View Our Latest Analysis on BKYI
About BIO-key International
BIO-key International, Inc (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords.
Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.
See Also
- Five stocks we like better than BIO-key International
- 1 Frozen Housing Market, 2 Very Different Earnings Stories
- 3 Energy Stocks Boosting Dividends as the Sector Widens Its 2026 Performance Lead
- Garmin Raises Its Profit Outlook—Can the Stock Reach New Highs?
- Why Rising Rates Could Break the Bull Market Before AI Spending Can Save It
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
